Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Determining whether real estate or stocks are better for your investments requires careful analysis. Weigh the advantages of each option.
26,575 articlesTG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Virgin Galactic rockets Monday sparked a split in space stocks as investors rotate away from launch-focused names. Ri...
When a billionaire like David Tepper reportedly sold stakes in Nvidia and Amazon, it raises questions for regular inv...
Major brokerages issued new research on top names like Airbnb, Broadcom, Chipotle, and NVIDIA as investors rotate str...
With the Fed chair signaling a hawkish tilt, markets brace for higher-for-longer policy. History suggests the last ti...
U.S. stocks climbed as data suggested resilience in growth and jobs. Analysts weigh whether the economy really perfor...
IBM leads the Dow movers while Sherwin-Williams slides, as analysts clash over Salesforce and the software rotation t...
Micron stock has faced a pullback as market focus shifts from AI optimism to risk management. This article breaks dow...
March has brought renewed volatility as Tencent Music reports mixed results, boosting questions about user metrics an...
Oil around $75 invites questions about ConocoPhillips stock. This guide breaks down how to assess COP, weigh oil sens...
Two Invesco health care ETFs offer different paths to play the GLP-1 revolution. This guide breaks down how invesco's...
Two popular healthcare ETFs—IHE and IBB—offer very different routes to exposure: established pharma vs biotech innova...